Capital Flow Monitor · Sponsors · CIK 2136090
TenNor Therapeutics (Suzhou) Ltd
UNIT 701, BLOCK B7, BIOBAY, SUZHOU, F4, 215123 · 008651286861990
Biotechnology · Corporation· inc. CHINA true
Fit score
—
Offering
$14.7M
Sold
$14.7M
% sold
100.0%
Investors
1
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | D ·current | 506(b) | $14.7M | $14.7M | 100.0% | 1 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Zhenkun Ma — Executive Officer / Director, Suzhou, F4
- Gaoguang Song — Director, Beijing, F4
- Michael James Bakes — Director, Dallas, TX
- Wai Kong Lee — Director, Hong Kong, K3
- Lin Ni — Director, Shanghai, F4
- Leping Li — Director, Shanghai, F4
- Jie Bi — Executive Officer, Suzhou, F4
- Guozhu Geng — Executive Officer, Suzhou, F4
-
Jing Chen — Executive Officer, SuzhOu, F4
1 other raise
- Harvard Apparatus Regenerative Technology, Inc. $2.8M of $3.0M · 94.6%
- Yinjiao Yu — Executive Officer, Suzhou, F4
- Rongping Chen — Executive Officer, Suzhou, F4
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.